1060
S. Hanelt, J. Liebscher
LETTER
128.7 (CHPh), 134.2 (NNNCH2C), 136.3 (NCOOCH2C),
(11) (a) Gil, M. V.; Arevalo, M. J.; Lopez, O. Synthesis 2007,
1589. (b) Zeitler, K.; Mager, I. Adv. Synth. Catal. 2007, 349,
1851.
(12) Geci, I.; Filichev, V. V.; Pedersen, E. B. Chem. Eur. J. 2007,
13, 6379.
(13) Lenda, F.; Guenoun, F.; Martinez, J.; Lamaty, F.
Tetrahedron Lett. 2007, 48, 805.
(14) Castagnolo, D.; Dessi, F.; Radi, M.; Botta, M. Tetrahedron:
Asymmetry 2007, 18, 1345.
142.6 (CHCOOCH2C), 154.2 (NCOOCH2Ph), 172.2
(CHCOOCH2).
Compound 3g: [a]D25 –260.7 (c 0.033, CHCl3). H NMR
(300.13 MHz, CDCl3): d = 0.83 (t, J = 6.5 Hz, 3 H,
CH2CH2CH2CH2CH3), 1.27 (m, 5 H, CH2CH2CH2CH2CH3
+ NCbzCHCHH), 1.61 (m, 3 H, NCbzCHCHHCH2), 1.89
(m, 2 H, CH2CH2CH2CH2CH3), 2.60 (m, 2 H,
CH2CH2CH2CH2CH3), 3.15 (m, 1 H, NCbzCHH), 3.33 (m,
1 H, NCbzCHH), 4.10 (m, 1 H, NCbzCH), 4.48 (m, 2 H,
CHCH2NNN), 5.13 (m, 2 H, PhCH2), 6.88 (s, 0.7 H,
CHtriazole), 7.10 (s, 0.3 H, CHtriazole), 7.31 (m, 5 H, Ph).
13C NMR (75.47 MHz, CDCl3): d = 13.8
(15) Gompper, R. Chem. Ber. 1957, 90, 382.
(16) Wamhoff, H. 1,2,3-Triazoles and their Benzo Derivatives;
Pergamon Press: Oxford / New York / Sydney, 1984.
(17) Begtrup, M. Acta Chem. Scand. 1971, 25, 249.
(18) Kaplan, G.; Drake, G.; Tollison, K.; Hall, L.; Hawkins, T.
J. Heterocycl. Chem. 2005, 42, 19.
(CH2CH2CH2CH2CH3), 22.2 (CH2CH2CH2CH2CH3), 23.1
(NCbzCHCHH), 25.3 (CH2CH2CH2CH2CH3), 27.8
(CH2CH2CH2CH2CH3), 28.9 (NCbzCHCH2CH2), 31.1
(CH2CH2CH2CH2CH3), 46.8 (NCbzCH2), 51.5 (CH2NNN),
57.1 (CHCH2NNN), 66.9 (PhCH2), 121.2 (CHtriazole), 127.7–
128.4 (CHPh), 136.3 (CPh), 148.3 (Ctriazole), 154.5 (NCOO).
Compound 5a: 1H NMR (400.13 MHz, CD3CN): d = 0.92
(t, J = 7.6 Hz, 3 H, CH2CH2CH2CH3), 1.40 (sext, J = 7.4 Hz,
2 H, CH2CH2CH2CH3), 1.65 (m, 2 H, CH2CH2CH2CH3),
2.81 (t, J = 7.2 Hz, 2 H, CH2CH2CH2CH3), 4.12 (s, 3 H,
N+Me), 5.82 (s, 2 H, CH2NNN), 7.46 (m, 5 H, Ph), 8.70 (s,
1 H, CH). Signals at d = 2.81 and 4.12 ppm showed a weak
(19) Drake, G.; Kaplan, G.; Hall, L.; Hawkins, T.; Larue, J.
J. Chem. Cryst. 2007, 37, 15.
(20) Preparation of 3; General Procedure: The azide 1 (20
mmol) was dissolved in the appropriate solvent (50 mL) and
CuI (see Table 1) was added. The flask was flushed with
argon and the mixture was kept under argon until the workup
procedure (balloon) was followed. DIPEA (see Table 1) and
the alkyne 2 (10 mmol) were added one after the other, the
latter in portions under stirring. If the alkyne was a solid or a
sticky liquid, the solvent quantity of 50 mL was shared for
dissolving the azide and the alkyne. After a short time an
exothermic reaction started and the pace of the addition of
the alkyne was adjusted accordingly. Cooling by a water-
bath might be advisable. After complete addition of the
alkyne stirring was continued at r.t. The mixture was diluted
with CHCl3 (50 mL) and filtered. The filtrate was evaporated
and the residue was purified by column chromatography
(Kieselgel 60; MeOH–CHCl3, 1:19). If DMF was used as
solvent, the reaction mixture was diluted with CHCl3 (250
mL), filtered and the filtrate was washed with H2O (3 × 150
mL) and dried with Na2SO4 before volatile compounds were
removed under vacuum. Eventually the washing procedure
had to be repeated.
cross peak with each other in the NOESY spectrum. 13
C
NMR (100.61 MHz, CD3CN): d = 13.5 (CH2CH2CH2CH3),
22.2 (CH2CH2CH2CH3), 23.4 (CH2CH2CH2CH3), 29.0
(CH2CH2CH2CH3), 38.5 (N+Me), 57.1 (PhCH2), 117.9
(CHtriazole), 128.8 (CHo), 129.6 (CHm), 130.0 (CHp), 133.0
(CPh), 145.5 (Ctriazole).
Compound 5e: [a]D25 –36.1 (c 0.024, CHCl3). 1H NMR
(300.13 MHz, CDCl3): d = 1.87 (m, 4 H, NCbzCHCH2CH2),
3.40 (m, 2 H, NCbzCH2), 4.06 (s, 3 H, N+Me), 4.21 (m, 1 H,
NCbzCH), 4.89 (m, 2 H, PhCH2NNN), 5.45 (m, 2 H,
COOCH2), 5.34 (s, 1 H, NCOOCH2Ph), 5.42 (s, 1 H,
NCOOCH2Ph), 7.27 (m, 10 H, 2 × Ph), 8.87 (s, 1 H,
CHtriazole). 13C NMR (75.47 MHz, CDCl3): d = 23.1
(NCbzCH2CH2), 29.9 (NCbzCHCH2), 39.3 (N+Me), 46.3
(NCbzCH2), 54.2 (PhCH2NNN), 57.0 (COOCH2), 58.6
(NCbzCH), 66.5 (PhCH2OCON), 123.3 (CHtriazole), 127.0–
130.6 (CHPh), 135.9 (NNNCH2C), 138.3 (NCOOCH2C),
142.3 (CHCOOCH2C), 153.9 (NCOOCH2Ph), 171.5
(CHCOOCH2).
Preparation of 5; General Procedure: A solution of the
1,2,3-triazole 3 (20 mL) and the alkylating reagent 4 (see
Table 1) in anhyd MeCN (30 mL) was refluxed (see
Table 1). All volatile compounds were removed under
vacuum with a rotary evaporator leaving behind the ionic
liquid as an oil or a sticky oil.
Compound 3a: 1H NMR (300.13 MHz, CDCl3): d = 0.87 (t,
J = 7.2 Hz, 3 H, CH2CH2CH2CH3), 1.32 (sext, J = 7.4 Hz, 2
H, CH2CH2CH2CH3), 1.58 (m, 2 H, CH2CH2CH2CH3), 2.68
(t, J = 7.8 Hz, 2 H, CH2CH2CH2CH3), 5.46 (s, 2 H,
CH2NNN), 7.19 (s, 1 H, CH), 7.27 (m, 5 H, Ph). 13C NMR
(75.47 MHz, CDCl3): d = 13.7 (CH2CH2CH2CH3), 22.1
(CH2CH2CH2CH3), 25.3 (CH2CH2CH2CH3), 31.3
(CH2CH2CH2CH3), 53.8 (PhCH2), 120.5 (CHtriazole), 127.8
(CHo), 128.4 (CHm), 128.9 (CHp), 134.8 (CPh), 148.8
(Ctriazole).
Compound 5g: [a]D25 –72.9 (c 0.02, CHCl3). 1H NMR
(300.13 MHz, CD3CN): d = 0.87 (t, J = 6.5 Hz, 3 H,
CH2CH2CH2CH2CH3), 1.31 (m, 5 H, CH2CH2CH2CH2CH3
+ NCbzCHCHH), 1.58 (m, 3 H, NCbzCHCHHCH2), 1.87
(m, 2 H, CH2CH2CH2CH2CH3), 2.39 (m, 2 H,
CH2CH2CH2CH2CH3), 3.16 (m, 1 H, NCbzCHH), 3.34 (m,
1 H, NCbzCHH), 3.90 (m, 1 H, NCbzCH), 4.07 (s, 3 H,
N+Me), 4.51 (m, 2 H, CHCH2NNN), 5.12 (m, 2 H, PhCH2),
7.35 (m, 5 H, Ph), 8.55 (s, 1 H, CHtriazole). 13C NMR (75.47
MHz, CD3CN): d = 14.0 (CH2CH2CH2CH2CH3), 22.6
(CH2CH2CH2CH2CH3), 23.5 (NCbzCHCHH), 25.7
(CH2CH2CH2CH2CH3), 27.1 (CH2CH2CH2CH2CH3), 28.6
(NCbzCHCH2CH2), 31.2 (CH2CH2CH2CH2CH3), 38.3
(N+Me), 47.3 (NCbzCH2), 51.6 (CH2NNN), 57.6
(CHCH2NNN), 67.0 (PhCH2), 118.1 (CHtriazole), 128.1–
129.7 (CHPh), 137.8 (CPh), 146.8 (Ctriazole), 155.6 (NCOO).
(21) Fazio, F.; Bryan, M. C.; Blixt, O.; Paulson, J. C.; Wong, C.
H. J. Am. Chem. Soc. 2002, 124, 14397.
Compound 3e: [a]D25 –80.3 (c 0.02, CHCl3). 1H NMR
(300.13 MHz, CDCl3): d = 1.96 (m, 4 H, NCbzCHCH2CH2),
3.48 (m, 2 H, NCbzCH2), 4.30 (m, 1 H, NCbzCH), 5.00 (m,
2 H, PhCH2NNN), 5.17 (m, 2 H, COOCH2), 5.34 (s, 1 H,
NCOOCH2Ph), 5.42 (s, 1 H, NCOOCH2Ph), 7.23 (m, 10 H,
2 × Ph), 7.56 (s, 1 H, CHtriazole). 13C NMR (75.47 MHz,
CDCl3): d = 23.5 (NCbzCH2CH2), 30.0 (NCbzCHCH2), 46.4
(NCbzCH2), 53.7 (PhCH2NNN), 57.9 (COOCH2), 58.7
(NCbzCH), 66.5 (PhCH2OCON), 123.3 (CHtriazole), 127.2–
Synlett 2008, No. 7, 1058–1060 © Thieme Stuttgart · New York